Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > I-PHARM CONSULTING INTERNATIONAL LIMITED
Company Information for

I-PHARM CONSULTING INTERNATIONAL LIMITED

LEVEL 7, 8 DEVONSHIRE SQUARE, LONDON, EC2M 4YJ,
Company Registration Number
08389470
Private Limited Company
Active

Company Overview

About I-pharm Consulting International Ltd
I-PHARM CONSULTING INTERNATIONAL LIMITED was founded on 2013-02-05 and has its registered office in London. The organisation's status is listed as "Active". I-pharm Consulting International Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
I-PHARM CONSULTING INTERNATIONAL LIMITED
 
Legal Registered Office
LEVEL 7
8 DEVONSHIRE SQUARE
LONDON
EC2M 4YJ
Other companies in SW6
 
Filing Information
Company Number 08389470
Company ID Number 08389470
Date formed 2013-02-05
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/12/2022
Account next due 30/09/2024
Latest return 05/02/2016
Return next due 05/03/2017
Type of accounts SMALL
Last Datalog update: 2024-03-06 23:29:01
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for I-PHARM CONSULTING INTERNATIONAL LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of I-PHARM CONSULTING INTERNATIONAL LIMITED

Current Directors
Officer Role Date Appointed
STEVEN JAMES LAMPORT-WENT
Company Secretary 2013-02-05
ISSAM ADIL AL-TARAFI
Director 2013-02-05
STEVEN JAMES LAMPORT-WENT
Director 2013-02-05
COLIN JOHN LYNAM
Director 2013-02-05
STEPHEN PETER MCANANEY
Director 2013-02-05

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
ISSAM ADIL AL-TARAFI PARALLEL GROUP LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
ISSAM ADIL AL-TARAFI I-PHARM CONSULTING GROUP LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
ISSAM ADIL AL-TARAFI APOLLO SOLUTIONS GROUP LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
ISSAM ADIL AL-TARAFI PANGEA INTERNATIONAL LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
ISSAM ADIL AL-TARAFI PANGEA RESOURCING LIMITED Director 2009-09-23 CURRENT 2009-09-23 Active
ISSAM ADIL AL-TARAFI I-PHARM CONSULTING LIMITED Director 2008-03-20 CURRENT 2008-03-20 Active
ISSAM ADIL AL-TARAFI APOLLO SOLUTIONS LIMITED Director 2007-12-14 CURRENT 2007-12-14 Active
ISSAM ADIL AL-TARAFI ATLAS FINANCIAL MARKETS LIMITED Director 2007-12-07 CURRENT 2007-12-07 Active - Proposal to Strike off
ISSAM ADIL AL-TARAFI PARALLEL CONSULTING LIMITED Director 2004-04-21 CURRENT 2004-04-21 Active
STEVEN JAMES LAMPORT-WENT PARALLEL GROUP LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
STEVEN JAMES LAMPORT-WENT I-PHARM CONSULTING GROUP LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
STEVEN JAMES LAMPORT-WENT APOLLO SOLUTIONS GROUP LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
STEVEN JAMES LAMPORT-WENT PANGEA INTERNATIONAL LIMITED Director 2017-09-29 CURRENT 2017-09-29 Active
STEVEN JAMES LAMPORT-WENT PANGEA RESOURCING LIMITED Director 2009-09-23 CURRENT 2009-09-23 Active
STEVEN JAMES LAMPORT-WENT I-PHARM CONSULTING LIMITED Director 2008-03-20 CURRENT 2008-03-20 Active
STEVEN JAMES LAMPORT-WENT APOLLO SOLUTIONS LIMITED Director 2007-12-14 CURRENT 2007-12-14 Active
STEVEN JAMES LAMPORT-WENT ATLAS FINANCIAL MARKETS LIMITED Director 2007-12-07 CURRENT 2007-12-07 Active - Proposal to Strike off
STEVEN JAMES LAMPORT-WENT PARALLEL CONSULTING LIMITED Director 2004-04-21 CURRENT 2004-04-21 Active
STEVEN JAMES LAMPORT-WENT WHITE KNIGHT VENTURES LIMITED Director 2004-04-20 CURRENT 2004-04-20 Active
STEPHEN PETER MCANANEY I-PHARM CONSULTING LIMITED Director 2008-03-20 CURRENT 2008-03-20 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-02-09CONFIRMATION STATEMENT MADE ON 05/02/24, WITH NO UPDATES
2023-10-18REGISTERED OFFICE CHANGED ON 18/10/23 FROM 3rd Floor, 52 Bedford Row London WC1R 4LR England
2023-10-18Change of details for I-Pharm Consulting Limited as a person with significant control on 2023-10-18
2023-02-17CONFIRMATION STATEMENT MADE ON 05/02/23, WITH NO UPDATES
2023-02-17Change of details for I-Pharm Consulting Limited as a person with significant control on 2023-02-17
2022-10-24AD01REGISTERED OFFICE CHANGED ON 24/10/22 FROM 3rd Floor 22 Long Acre London WC2E 9LY England
2022-09-30FULL ACCOUNTS MADE UP TO 31/12/21
2022-09-30AAFULL ACCOUNTS MADE UP TO 31/12/21
2022-02-23CS01CONFIRMATION STATEMENT MADE ON 05/02/22, WITH UPDATES
2022-02-23PSC05Change of details for I-Pharm Consulting Limited as a person with significant control on 2021-07-13
2022-02-23PSC07CESSATION OF COLIN JOHN LYNAM AS A PERSON OF SIGNIFICANT CONTROL
2021-12-01AD01REGISTERED OFFICE CHANGED ON 01/12/21 FROM The Warehouse 212 New King’S Road London SW6 4NZ United Kingdom
2021-09-13AAFULL ACCOUNTS MADE UP TO 31/12/20
2021-02-08CS01CONFIRMATION STATEMENT MADE ON 05/02/21, WITH NO UPDATES
2020-11-18AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/19
2020-03-09AUDAUDITOR'S RESIGNATION
2020-02-05CS01CONFIRMATION STATEMENT MADE ON 05/02/20, WITH UPDATES
2019-09-25AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/18
2019-02-09CS01CONFIRMATION STATEMENT MADE ON 05/02/19, WITH UPDATES
2018-09-28AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/17
2018-02-05LATEST SOC05/02/18 STATEMENT OF CAPITAL;GBP 100
2018-02-05CS01CONFIRMATION STATEMENT MADE ON 05/02/18, WITH UPDATES
2018-02-05CH01Director's details changed for Mr Colin John Lynam on 2018-02-05
2018-02-05PSC04Change of details for Mr Colin John Lynam as a person with significant control on 2018-02-05
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR STEPHEN PETER MCANANEY / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR COLIN JOHN LYNAM / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR STEVEN JAMES LAMPORT-WENT / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR ISSAM ADIL AL-TARAFI / 23/09/2017
2017-09-23CH03SECRETARY'S CHANGE OF PARTICULARS / STEVEN JAMES LAMPORT-WENT / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR STEPHEN PETER MCANANEY / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR COLIN JOHN LYNAM / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR STEVEN JAMES LAMPORT-WENT / 23/09/2017
2017-09-23CH01DIRECTOR'S CHANGE OF PARTICULARS / MR ISSAM ADIL AL-TARAFI / 23/09/2017
2017-09-23CH03SECRETARY'S CHANGE OF PARTICULARS / STEVEN JAMES LAMPORT-WENT / 23/09/2017
2017-08-23AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/16
2017-04-24CH01Director's details changed for Issam Adil Al-Tarafi on 2017-04-20
2017-03-22CH01Director's details changed for Mr Stephen Peter Mcananey on 2017-03-19
2017-02-08LATEST SOC08/02/17 STATEMENT OF CAPITAL;GBP 100
2017-02-08CS01CONFIRMATION STATEMENT MADE ON 05/02/17, WITH UPDATES
2017-02-07CH01Director's details changed for Colin John Lynam on 2017-02-07
2016-10-05AAFULL ACCOUNTS MADE UP TO 31/12/15
2016-02-24LATEST SOC24/02/16 STATEMENT OF CAPITAL;GBP 100
2016-02-24AR0105/02/16 ANNUAL RETURN FULL LIST
2015-09-28AD01REGISTERED OFFICE CHANGED ON 28/09/15 FROM Grayton House, 498-504 Fulham Road London SW6 5NH
2015-07-31AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/14
2015-02-16LATEST SOC16/02/15 STATEMENT OF CAPITAL;GBP 100
2015-02-16AR0105/02/15 ANNUAL RETURN FULL LIST
2014-09-24AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/13
2014-03-17LATEST SOC17/03/14 STATEMENT OF CAPITAL;GBP 100
2014-03-17AR0105/02/14 ANNUAL RETURN FULL LIST
2014-03-17AD01REGISTERED OFFICE CHANGED ON 17/03/14 FROM Grayton House 498 Fulham Road London SW6 5NH United Kingdom
2013-03-06CH01DIRECTOR'S CHANGE OF PARTICULARS / COLIN JOHN LYNAM / 05/02/2013
2013-03-06CH01DIRECTOR'S CHANGE OF PARTICULARS / ISSAM ADIL AL-TARAFI / 05/02/2013
2013-03-06CH03SECRETARY'S CHANGE OF PARTICULARS / STEVEN JAMES LAMPORT-WENT / 05/02/2013
2013-02-26AA01CURRSHO FROM 28/02/2014 TO 31/12/2013
2013-02-26CH01DIRECTOR'S CHANGE OF PARTICULARS / MR STEPHEN PETER MCANANEY / 05/02/2013
2013-02-26CH01DIRECTOR'S CHANGE OF PARTICULARS / MR STEVEN JAMES LAMPORT-WENT / 05/02/2013
2013-02-07AP01DIRECTOR APPOINTED COLIN JOHN LYNAM
2013-02-05NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
64 - Financial service activities, except insurance and pension funding
642 - Activities of holding companies
64209 - Activities of other holding companies n.e.c.

74 - Other professional, scientific and technical activities
749 - Other professional, scientific and technical activities n.e.c.
74990 - Non-trading company



Licences & Regulatory approval
We could not find any licences issued to I-PHARM CONSULTING INTERNATIONAL LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against I-PHARM CONSULTING INTERNATIONAL LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
I-PHARM CONSULTING INTERNATIONAL LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 64209 - Activities of other holding companies n.e.c.

Filed Financial Reports
Annual Accounts
2020-12-31
Annual Accounts
2021-12-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on I-PHARM CONSULTING INTERNATIONAL LIMITED

Intangible Assets
Patents
We have not found any records of I-PHARM CONSULTING INTERNATIONAL LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for I-PHARM CONSULTING INTERNATIONAL LIMITED
Trademarks
We have not found any records of I-PHARM CONSULTING INTERNATIONAL LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for I-PHARM CONSULTING INTERNATIONAL LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (64209 - Activities of other holding companies n.e.c.) as I-PHARM CONSULTING INTERNATIONAL LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where I-PHARM CONSULTING INTERNATIONAL LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded I-PHARM CONSULTING INTERNATIONAL LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded I-PHARM CONSULTING INTERNATIONAL LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.